Description
Specific anatagonist of apelin-13. Systemic administration of Apelin-13 F13A (30 µg/kg) abolished the blood pressure-lowering effects of apelin-13 (15 µg/kg) in hypertensive rats.
Specific anatagonist of apelin-13. Systemic administration of Apelin-13 F13A (30 µg/kg) abolished the blood pressure-lowering effects of apelin-13 (15 µg/kg) in hypertensive rats.
Specific anatagonist of apelin-13. Systemic administration of Apelin-13 F13A (30 µg/kg) abolished the blood pressure-lowering effects of apelin-13 (15 µg/kg) in hypertensive rats.
| Pack size available | 1mg, 5mg |
|---|